Carig

Carig 1200IU Injection is more economical as compared to human rabies immunoglobulin (HRIG) and hence more affordable to patients in developing countries, like India. However, Carig 1200IU Injection may cause anaphylaxis (a severe, potentially life-threatening allergic reaction), serum sickness and other allergic reactions and thus, physicians are hesitant to use it.

Rabies is a 100% preventable disease. Proper wound management and simultaneous administration of Carig 1200IU Injection combined with anti-rabies vaccine (ARV) is almost invariably effective in preventing rabies, even after high-risk exposure.

Carig 1200IU Injection is not required for patients who have previously received a complete vaccination series of rabies.

Carig 1200IU Injection should be administered into the muscle (the intramuscularly). If a large volume (> 2mL for children or > 5 mL for adults) is required, it is advised to divide the doses and for each dose a different site should be used. The immunoglobulin and the anti-rabies vaccine should be administered at two different sites of the body.

Whether Carig 1200IU Injection is painful or not depends on your pain tolerance. During your initial treatment, a healthcare professional will put Carig 1200IU Injection in the area where you were bitten which can be painful. Therefore, you may need a relatively greater amount of Carig 1200IU Injection may be required to be placed in and around the wound site to ease out your pain and treat infection.